February 1, 2013

We are even more encouraged by the activities at the SDBC with the production buildup for attacking the Parkinson’s protein of LRRK2. In the...

December 29, 2012

The management of the San Diego Biotech Company (SDBC) has every reason to thank God for His grace and its investors whose financial contributions...

December 1, 2012

This month, the San Diego Biotech Company (SDBC) received some additional data from their collaborator, Dr. E. Masliah, UCSD Department of Neurosciences. This data...

November 27, 2012

The San Diego Biotech Company (SDBC) is continuing its efforts to speed up the development of diagnostics and therapeutics for Parkinson’s disease. 1. Dr. Anna...

October 3, 2012

Watching the science on the ROAD TO CURE PARKINSON’S, in order to excel the development of diagnostics and therapeutics for Parkinson’s disease, the San...

September 1, 2012

The failure of a recent large clinical trial of one of the Alzheimer’s drugs, Bapineuzumab, undertaken by pharmaceutical giants Johnson and Johnson, Pfizer and...

August 18, 2012

The biotech company in San Diego, in collaboration with Dr. Masliah of UCSD, had commenced the Blood-Brain Barrier study with its a-synuclein-picobody in Parkinson’s-like...

July 1, 2012

As you’ve been following the “Road to a Cure” project we are delighted to report the momentum that is taking place. Just to make sure...

June 5, 2012

It has been a long and slow journey to develop a curative treatment for Parkinson’s disease, which was discovered nearly 200 years ago. Billions of...

April 3, 2012

Neurodegenerative diseases such as Parkinson’s have been inert to medicinal treatment partly because most drugs cannot reach the central nervous system (CNS). Why? There...

September 5, 2011

“It’s such a departure from what we thought,” said Dr. Dennis Selkoe. A provocative new study by Harvard Medical School researchers suggests that a basic...